Outcome of Board Meeting dated 10.02.2026.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
The Board of Directors of Adline Chem Lab Ltd met on 10th February 2026 and approved the Unaudited Standalone Financial Results for Q3 FY26 (quarter ended 31st December 2025) along with results for the nine months ended on the same date. The statutory auditors (Jain Kedia & Sharma) issued a clean Limited Review Report with no qualifications or modifications. The company reported a net loss of Rs 6.46 lakhs for the quarter and Rs 18.85 lakhs for the nine months, an improvement from the Rs 34.16 lakhs loss in the comparable nine-month period last year. The Board also approved the appointment of Mr. Vrushank Balkrushna Patel as Chairman & Managing Director for five years, replacing Mr. Sarang Pathak.
For shareholders: While the company remains loss-making, the narrowing of losses compared to last year is a mild positive signal. The leadership change at the top may signal strategic direction shifts. The stock is a small-cap with limited revenue base (Rs 24.89 lakhs in other income for Q3), so this filing is largely procedural and unlikely to move the share price meaningfully.